Exciting News! SBK Named 2024 “Chengdu Enterprise Technology Center”

On October 9, the Chengdu Municipal Bureau of Economy and Information Technology announced the provisional list for the 2024 “Chengdu Enterprise Technology Center”, and we are thrilled to share that Chengdu Shibeikang Biomedical Technology Co., Ltd. has been successfully selected for this prestigious designation. This recognition highlights the company’s achievements in technological innovation, talent development, and organizational management, marking a key milestone in SBK’s growth journey.

Since its founding, SBK has prioritized building strong technological innovation capabilities, focusing on differentiated innovation. The company has strengthened its “moat” of patented inventions and refined its management systems, achieving impressive results in the R&D of innovative chemical drugs.

Looking ahead, SBK will continue to implement an innovation-driven development strategy, increasing R&D investments in the “Enterprise Technology Center” innovation platform. The company is committed to advancing technological innovation, overcoming technical challenges, and further enhancing its innovation capabilities, all while pursuing its vision of “Becoming a world leader in the differentiated innovation of novel drugs”.